Researchers urge delay in administering Pfizer vaccine's second dose


Modified 18 Feb 2021, 9:30 am

Researchers on Wednesday urged governments to delay administering the second dose of Pfizer Inc’s Covid-19 vaccine, which they said had an efficacy of 92.6 percent after the first dose.

The researchers, Danuta Skowronski and Gaston De Serres, said their findings were derived from Pfizer’s documents submitted to the US Food and Drug Administration...

All Access Plan
starting from


per month
Subscribe Now
You can cancel anytime.
Get unlimited access to our articles on web and apps
Add comments to our articles
Bookmark articles to read later
We accept
Student or Senior Citizen? Get a special rateGroup / Institutional / Corporate Plans
Already Subscribed?
Sign In